Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
Medical tests
Dataset Records for Medical tests
Displaying 51 - 100 of 1086
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey
GHDx Entry last modified on: Aug 1, 2022
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020
Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19
Epi surveillance:
Household - Interview - Urban-rural representative
Canada COVID-19 Seroprevalence in Ontario: July 4 to July 31, 2020
GHDx Entry last modified on: May 12, 2022
United States - Ohio Prevalence of Current and Past COVID-19 in Adults July 2020
Prevalence of Current and Past COVID-19 in Ohio Adults
Survey:
Epi surveillance - Individual
Oman COVID-19 National Serological Survey Phase 1 2020
National Sero-Survey of COVID-19 Infection First Phase
Survey:
Cross-sectional - Epi surveillance
Epidemiological and Serological Surveillance of COVID-19 in Pune City, Technical Report, August 16, 2020
Technical Report (dt August 16, 2020): Epidemiological and Serological Surveillance of COVID-19 in Pune City
Survey:
Epi surveillance
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Mar 14, 2022
Premise Malaria COVID-19 Health Services Disruption Survey 2020
Survey:
Cross-sectional - Individual
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
CDC COVID Data Tracker Nationwide Blood Donor Seroprevalence Survey 2021-2022
Survey:
Epi surveillance - Subnationally representative
The Burden of COVID-19 Infection in a Rural Tamil Nadu Community. Preprint
GHDx Entry last modified on: Mar 14, 2022
Norway SARS-CoV-2 Seroprevalence Residual Sera Follow-up Survey July-September 2020
Seroprevalence of SARS-CoV-2 in the Norwegian population measured in residual sera collected in late summer 2020
Survey:
Epi surveillance - Individual
Israel - Press Releases Results of the National Serological Survey for Novel Coronavirus
GHDx Entry last modified on: May 12, 2022
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Feb 10, 2022
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Mar 14, 2022
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
Sero-prevalence of SARS-CoV-2 Antibody Among Adults in the General Population in Diredawa, Ethiopia. Preprint
GHDx Entry last modified on: Sep 13, 2022
Colombia - Bogota Sabana University Clinic Long Covid Cohort Study 2020-2022
Survey:
Emergency - Exam - Health facility - Individual - Inpatient - Interview - Longitudinal
Rapid increase of SARS-CoV-2 seroprevalence during the 2020 pandemic year in the population of the city of Tirana, Albania. Preprint
GHDx Entry last modified on: May 12, 2022
Health Minister Fahrettin Koca announced the results of Turkey's antibody test
Sağlık Bakanı Fahrettin Koca Türkiye’nin antikor testi sonuçlarını açıkladı
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic. Preprint
GHDx Entry last modified on: Oct 6, 2022
SARS-CoV-2 seroprevalence and characteristics of post-infection immunity in a general population cohort study in Catalonia, Spain. Preprint
GHDx Entry last modified on: May 12, 2022
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: May 12, 2022
Afghanistan National COVID-19 Prevalence and Related Deaths Survey 2020
National Survey of Prevalence of COVID-19 and its Related Deaths in Afghanistan
Survey:
Cross-sectional - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Popova declared immunity to coronavirus in 14% of those tested
Попова заявила об иммунитете к коронавирусу у 14% протестированных
Suriname COVID-19 Situation Report 2020
GHDx Entry last modified on: May 12, 2022
United Kingdom Coronavirus (COVID-19) Infection Survey Pilot Statistical Bulletins 2020
Coronavirus (COVID-19) Infection Survey, UK Statistical bulletins
Portugal National Serological Survey COVID-19 Preliminary results 2020
Relatório de Apresentação dos Resultados Preliminares do Primeiro Inquérito Serológico Nacional COVID-19
United Kingdom Coronavirus (COVID-19) Infection Survey 2020-2021
GHDx Entry last modified on: Aug 24, 2023
Canada - Quebec COVID-19 First Wave Blood Donor Seroprevalence Study 2020
Étude De Séroprévalence Des Anti-Sras-Cov-2 Chez Les Donneurs De Sang D’héma-Québec, Vers La Fin De La Première Vague De Covid-19
Survey:
Epi surveillance
Jersey SARS-CoV-2: Prevalence of antibodies in Jersey 2020
Survey:
Epi surveillance
Positive Rate of Serology and RT-PCR for COVID-19 between Community Residents and Healthcare Workers in Wuhan, China
GHDx Entry last modified on: Mar 14, 2022
[Martinez Benazet thanks institutions, volunteers and the population who have participated in the national antibody study]
Martinez Benazet agraeix a institucions, voluntaris i a la població que ha participat en l’estudi nacional d’anticossos
Survey:
Epi surveillance
In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2
Survey:
Longitudinal
Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil
GHDx Entry last modified on: Jun 17, 2021
South Sudan Daily COVID-19 Updates (Cases, Deaths, Hospitalization, Contact Tracing) 2020-2022
GHDx Entry last modified on: Jun 14, 2023
United Kingdom Coronavirus (COVID-19) Data Dashboard 2020-2022
GHDx Entry last modified on: Aug 24, 2023
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors
GHDx Entry last modified on: Mar 14, 2022
Estonia COVID-19 Coronavirus prevalence study 2020-2023
Koroonaviiruse levimuse uuring "Covid-19 aktiivne seire"
Survey:
Epi surveillance
United States - Idaho Division of Public Health COVID-19 Data 2020
GHDx Entry last modified on: Aug 24, 2023
Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors. Preprint
GHDx Entry last modified on: Mar 14, 2022
England - Coronavirus (COVID-19) Infection Survey: Antibody Data, January 2021
Coronavirus (COVID-19) Infection Survey: antibody data for the UK, January 2021
Survey:
Epi surveillance
Subscribe